Kiniksa Pharmaceuticals International (KNSA) EPS (Basic) (QoQ) (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) EPS (Basic) (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.51 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.62 Bn | 30.94 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.13 Bn | 5.60 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.03% |
| Mar 31, 2026 | 54.29% |
| Dec 31, 2025 | -22.44% |
| Sep 30, 2025 | 1.62% |
| Jun 30, 2025 | 106.58% |
| Mar 31, 2025 | 194.46% |
| Dec 31, 2024 | 29.68% |
| Sep 30, 2024 | -221.53% |
| Jun 30, 2024 | 78.04% |
| Mar 31, 2024 | 64.34% |
| Dec 31, 2023 | -256.07% |
| Sep 30, 2023 | -192.19% |
| Jun 30, 2023 | 221.73% |
| Mar 31, 2023 | -113.79% |
| Dec 31, 2022 | -60.46% |
| Sep 30, 2022 | 1,219.03% |
| Jun 30, 2022 | 20.92% |
| Mar 31, 2022 | 43.27% |
| Dec 31, 2021 | -44.49% |
| Sep 30, 2021 | 26.80% |